Related Experiment Video
Updated: Dec 17, 2025
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Intraaortic Balloon Pump Counterpulsation, Part I: History, Technical Aspects, Physiologic Effects,
Laura S González1, Mark A Chaney2
1From the Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Insights
Intra-aortic balloon pump counterpulsation is a common mechanical circulatory support for myocardial ischemia and cardiogenic shock. Despite its hemodynamic benefits, major trials have not conclusively proven improved outcomes, sparking ongoing debate.
Area of Science:
- Cardiology
- Mechanical Circulatory Support
Background:
- Intra-aortic balloon pump (IABP) counterpulsation is the primary mechanical circulatory support for myocardial ischemia and cardiogenic shock.
- Its mechanism involves diastolic augmentation and systolic afterload reduction, enhancing coronary perfusion and myocardial oxygen balance.
Observation:
- Major clinical trials have not definitively demonstrated significant improvements in morbidity and mortality for acute myocardial infarction (MI) or cardiogenic shock patients treated with IABP.
- The clinical utility and optimal application of counterpulsation therapy remain subjects of ongoing discussion and research.
Findings:
- Review of Part I covers IABP history, technical aspects, complications, and physiologic effects.
- Evidence for IABP in myocardial ischemia and cardiogenic shock is examined.
Implications:
- Understanding IABP's historical context, technicalities, and physiological impact is crucial for its clinical application.
- Further research is needed to clarify the definitive role of IABP in managing acute coronary syndromes and cardiogenic shock.
Abstract:
Intraaortic balloon pump counterpulsation is the most common form of mechanical circulatory support used in patients with myocardial ischemia and cardiogenic shock. The physiologic principles of counterpulsation include diastolic augmentation of aortic pressure and systolic reduction of left ventricular afterload, resulting in hemodynamic benefits through increased coronary perfusion pressure and improved myocardial oxygen balance in patients with myocardial ischemia. Major trials have failed to conclusively demonstrate improvements in morbidity and mortality with counterpulsation therapy for patients with acute myocardial infarction (MI), cardiogenic shock, and/or severe coronary artery disease undergoing revascularization therapy, and the debate over its applications continues. Part I of this review focuses on the history of the development of counterpulsation, technical considerations, and complications associated with its use, its physiologic effects, and evidence for its use in myocardial ischemia and cardiogenic shock.
More Related Videos
Related Concept Videos
01:17Measurement of Blood Pressure
01:17Aortic Regurgitation IV: Nursing Management